Ildikó Krencz

466 total citations
28 papers, 346 citations indexed

About

Ildikó Krencz is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ildikó Krencz has authored 28 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Ildikó Krencz's work include Cancer, Hypoxia, and Metabolism (13 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Neuroendocrine Tumor Research Advances (4 papers). Ildikó Krencz is often cited by papers focused on Cancer, Hypoxia, and Metabolism (13 papers), PI3K/AKT/mTOR signaling in cancer (11 papers) and Neuroendocrine Tumor Research Advances (4 papers). Ildikó Krencz collaborates with scholars based in Hungary, United States and Netherlands. Ildikó Krencz's co-authors include Anna Sebestyén, Titanilla Dankó, András Khoór, Gábor Petővári, Judit Pápay, András Jeney, Hajnalka Rajnai, Katalin Mészáros, Judit Moldvay and Katalin Fábián and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Ildikó Krencz

27 papers receiving 345 citations

Peers

Ildikó Krencz
Georgina Mancinelli United States
Hezhao Zhao China
Hanneke Stegeman Netherlands
Alan Kiang United States
Vincent Roh Switzerland
Liguo Ye China
Silvia Codenotti Italy
Asel Biktasova United States
Francia Fang United States
Georgina Mancinelli United States
Ildikó Krencz
Citations per year, relative to Ildikó Krencz Ildikó Krencz (= 1×) peers Georgina Mancinelli

Countries citing papers authored by Ildikó Krencz

Since Specialization
Citations

This map shows the geographic impact of Ildikó Krencz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ildikó Krencz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ildikó Krencz more than expected).

Fields of papers citing papers by Ildikó Krencz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ildikó Krencz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ildikó Krencz. The network helps show where Ildikó Krencz may publish in the future.

Co-authorship network of co-authors of Ildikó Krencz

This figure shows the co-authorship network connecting the top 25 collaborators of Ildikó Krencz. A scholar is included among the top collaborators of Ildikó Krencz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ildikó Krencz. Ildikó Krencz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dankó, Titanilla, Gábor Petővári, Gyula Végső, et al.. (2024). Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas. British Journal of Cancer. 130(7). 1119–1130. 1 indexed citations
2.
3.
Petővári, Gábor, Titanilla Dankó, Noémi Nagy, et al.. (2024). mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies. Pathology & Oncology Research. 30. 1611643–1611643. 1 indexed citations
4.
Dankó, Titanilla, Noémi Nagy, Judit Pápay, et al.. (2024). Increased mTOR activity and RICTOR copy number in small cell lung carcinoma progression. European Journal of Cell Biology. 103(4). 151468–151468. 1 indexed citations
5.
6.
Krencz, Ildikó, et al.. (2024). Rictor—A Mediator of Progression and Metastasis in Lung Cancer. Cancers. 16(3). 543–543. 3 indexed citations
7.
8.
Krencz, Ildikó, et al.. (2022). In Situ Analysis of mTORC1/C2 and Metabolism-Related Proteins in Pediatric Osteosarcoma. Pathology & Oncology Research. 28. 1610231–1610231. 4 indexed citations
9.
Farkas, Henriette, et al.. (2022). A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1. Allergy Asthma and Clinical Immunology. 18(1). 60–60. 1 indexed citations
10.
Dankó, Titanilla, Gábor Petővári, Péter Lőrincz, et al.. (2021). Rapamycin Plus Doxycycline Combination Affects Growth Arrest and Selective Autophagy-Dependent Cell Death in Breast Cancer Cells. International Journal of Molecular Sciences. 22(15). 8019–8019. 21 indexed citations
11.
Krencz, Ildikó, et al.. (2021). Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations. Cancer and Metastasis Reviews. 40(4). 1141–1157. 27 indexed citations
12.
Sebestyén, Anna, et al.. (2021). The role of metabolic ecosystem in cancer progression — metabolic plasticity and mTOR hyperactivity in tumor tissues. Cancer and Metastasis Reviews. 40(4). 989–1033. 26 indexed citations
13.
Németh, Kinga, Katalin Mészáros, Nikolette Szücs, et al.. (2020). Demethylation Status of Somatic DNA Extracted From Pituitary Neuroendocrine Tumors Indicates Proliferative Behavior. The Journal of Clinical Endocrinology & Metabolism. 105(6). 2015–2026. 7 indexed citations
14.
Krencz, Ildikó, Noémi Nagy, Gábor Petővári, et al.. (2020). Characterization of mTOR Activity and Metabolic Profile in Pediatric Rhabdomyosarcoma. Cancers. 12(7). 1947–1947. 8 indexed citations
15.
Sarkadi, Balázs, Katalin Mészáros, Ildikó Krencz, et al.. (2020). Glutaminases as a Novel Target for SDHB-Associated Pheochromocytomas/Paragangliomas. Cancers. 12(3). 599–599. 20 indexed citations
16.
Krencz, Ildikó, Anna Sebestyén, & András Khoór. (2020). mTOR in Lung Neoplasms. Pathology & Oncology Research. 26(1). 35–48. 20 indexed citations
17.
Petővári, Gábor, Titanilla Dankó, Ildikó Krencz, et al.. (2019). Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells. Pathology & Oncology Research. 26(1). 23–33. 16 indexed citations
18.
Petővári, Gábor, Ildikó Krencz, Titanilla Dankó, et al.. (2018). Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells. Cancer Cell International. 18(1). 211–211. 16 indexed citations
19.
Horváth, Gergő, Gábor Petővári, Ildikó Krencz, et al.. (2018). GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas. Journal of Experimental & Clinical Cancer Research. 37(1). 271–271. 30 indexed citations
20.
Petővári, Gábor, Norbert Szoboszlai, Titanilla Dankó, et al.. (2017). Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. Journal of Experimental & Clinical Cancer Research. 36(1). 74–74. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgina Mancinelli Breakdown of academic impact, for papers by Hezhao Zhao Breakdown of academic impact, for papers by Hanneke Stegeman Breakdown of academic impact, for papers by Alan Kiang Breakdown of academic impact, for papers by Vincent Roh Breakdown of academic impact, for papers by Liguo Ye Breakdown of academic impact, for papers by Silvia Codenotti Breakdown of academic impact, for papers by Asel Biktasova Breakdown of academic impact, for papers by Francia Fang
Rankless by CCL
2026